Why Weight? Obesity Management as a Treatment Goal for Patients with Type 2 Diabetes

Why Weight? Obesity Management as a Treatment Goal for Patients with Type 2 Diabetes is organized by Med Learning Group.,Release Date: May 31, 2022,Expiration Date: May 31, 2023,Program Overview:,This CME program has been designed to provide participants with the knowledge necessary to simultaneously address weight management and glycemic control in patients with type 2 diabetes and obesity/overweight. Participants will gain a greater understanding of guidelines-recommended pharmaceutical and lifestyle management strategies, and learn how incretin therapies with beneficial impacts on glycemic outcomes and body weight can be integrated into clinical practice. In addition to viewing a faculty presentation of relevant clinical data and guidelines, learners will participate in Med Games, an engaging gamified learning activity featuring interactive quizzes and video case studies that provide the opportunity to make decisions about patient care and get immediate feedback.,Learning Objectives:,On completing this program, attendees should be able to:,• Determine the rationale for simultaneously addressing weight management and glycemic control in patients with T2DM.,• Assess the benefits and limitations of lifestyle and pharmaceutical weight loss interventions for patients with T2DM.,• Apply knowledge of clinical data on incretin therapies and treatment intensification guidelines to care plans for patients with T2DM and obesity